Company Overview and News
Sandstorm gold posted record revenue of $19.5 million for the three months ended March 31, 2018, compared with $18.8 million for the comparable period in 2017.
In my opinion, the company is heading in the right direction: Sabodala performs well and the Wahgnion gold project in Burkina Faso is entering the development stage.
Good morning. My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sandstorm Gold conference call. All lines have been placed on mute to prevent any background noise.
Hummingbird Resources (OTCPK:HUMRF) has come a very long way since I covered the company in SA in November 2017. It poured first gold at its Yanfolila gold mine in Mali at the end of December 2017, and it achieved commercial production as of 1 April 2018. What’s remarkable in this case is that the project was delivered on time and on budget, which is pretty rare in the gold mining space.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
George Town, April 27th, 2018 - Endeavour Mining (TSX:EDV) (OTCQX:EDVMF) provides notice that it will release its financial results for the first quarter of 2018 on Tuesday, May 15th, before TSX market open. Management invites you to participate in a conference call and live webcast on the same day at 8:30am (EST) to discuss the Company's financial and operational results.
I see insider buying as mostly a positive sign; it implies that insiders are bullish on company stock and think the price will rise.
The following slide deck was published by Endeavour Mining Corporation in conjunction with their 2017 Q4 earnings call.
In the medium term Teranga share prices should be supported by the company's largest shareholder; since November 2017 this shareholder has purchased 2.05 million shares and is still buying.
Good morning. My name is Leonie and I'll be your conference operator today. At this time, I would like to welcome everyone to the Sandstorm Gold Fourth Quarter Results Conference Call. [Operator Instructions] Please be aware that some of the commentary may contain forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements.
Since it first began production in 2014, Agbaou gold mine in central Ivory Coast has been hit by protests
ABIDJAN, Feb 9 (Reuters) - Endeavour Mining has opened negotiations with local people in Ivory Coast in an effort to head off protests at two gold mines where the company aims to boost production by nearly 4 percent this year, its country manager said on Friday.
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
21h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
21h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...